Furuzakura capsules 1mg, manufactured by Takeda Pharmaceutical, contain Fruquintinib. This kinase inhibitor is used for the treatment of metastatic colorectal cancer and has a YJ code of 4291088M1024, standardized as 1mg per capsule.
Furuzakura capsules 1mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →